Related Experiment Video
Updated: Nov 20, 2025

Chromatin Isolation by RNA Purification ChIRP
Published on: March 25, 2012
Circulating long non-coding RNAs HOTAIR, Linc-p21, GAS5 and XIST expression profiles in diffuse large B-cell
Mahmoud A Senousy1, Aya M El-Abd2, Raafat R Abdel-Malek3
1Department of Biochemistry, Faculty of Pharmacy, Cairo University, 23 Kasr Al-Ainy street, Cairo, 11562, Egypt.
Abstract:
The reliable identification of diffuse large B-cell lymphoma (DLBCL)-specific targets owns huge implications for its diagnosis and treatment. Long non-coding RNAs (lncRNAs) are implicated in DLBCL pathogenesis; however, circulating DLBCL-related lncRNAs are barely investigated. We investigated plasma lncRNAs; HOTAIR, Linc-p21, GAS5 and XIST as biomarkers for DLBCL diagnosis and responsiveness to R-CHOP therapy. Eighty-four DLBCL patients and thirty-three healthy controls were included. Only plasma HOTAIR, XIST and GAS5 were differentially expressed in DLBCL patients compared to controls. Pretreatment plasma HOTAIR was higher, whereas GAS5 was lower in non-responders than responders to R-CHOP. Plasma GAS5 demonstrated superior diagnostic accuracy (AUC = 0.97) whereas a panel of HOTAIR + GAS5 superiorly discriminated responders from non-responders by ROC analysis. In multivariate analysis, HOTAIR was an independent predictor of non-response. Among patients, plasma HOTAIR, Linc-p21 and XIST were correlated. Plasma GAS5 negatively correlated with International Prognostic Index, whereas HOTAIR positively correlated with performance status, denoting their prognostic potential. We constructed the lncRNAs-related protein-protein interaction networks linked to drug response via bioinformatics analysis. In conclusion, we introduce plasma HOTAIR, GAS5 and XIST as potential non-invasive diagnostic tools for DLBCL, and pretreatment HOTAIR and GAS5 as candidates for evaluating therapy response, with HOTAIR as a predictor of R-CHOP failure. We provide novel surrogates for future predictive studies in personalized medicine.
Insights
Plasma long non-coding RNAs HOTAIR, GAS5, and XIST show promise as non-invasive biomarkers for diagnosing diffuse large B-cell lymphoma (DLBCL) and predicting response to R-CHOP therapy.
Area of Science:
- Oncology
- Molecular Biology
- Biomarkers
Background:
- Diffuse large B-cell lymphoma (DLBCL) requires reliable diagnostic and therapeutic targets.
- Long non-coding RNAs (lncRNAs) are involved in DLBCL pathogenesis but circulating lncRNAs remain understudied.
- Identifying circulating lncRNAs can improve DLBCL management.
Purpose of the Study:
- To investigate plasma lncRNAs (HOTAIR, Linc-p21, GAS5, XIST) as biomarkers for DLBCL diagnosis.
- To assess these lncRNAs' potential in predicting response to R-CHOP therapy.
- To explore the prognostic value of these lncRNAs in DLBCL patients.
Main Methods:
- Plasma samples from 84 DLBCL patients and 33 healthy controls were analyzed.
- Expression levels of HOTAIR, Linc-p21, GAS5, and XIST were quantified.
- Receiver operating characteristic (ROC) analysis and multivariate analysis were performed to evaluate diagnostic and predictive accuracy.
Main Results:
- Plasma HOTAIR, XIST, and GAS5 were differentially expressed in DLBCL patients versus controls.
- Pretreatment HOTAIR was higher in non-responders, while GAS5 was lower compared to responders.
- Plasma GAS5 showed high diagnostic accuracy (AUC=0.97); HOTAIR+GAS5 panel predicted treatment response; HOTAIR independently predicted non-response.
Conclusions:
- Plasma HOTAIR, GAS5, and XIST serve as potential non-invasive diagnostic biomarkers for DLBCL.
- Pretreatment HOTAIR and GAS5 can predict R-CHOP therapy response, with HOTAIR indicating R-CHOP failure.
- These lncRNAs offer novel surrogates for personalized medicine and predictive studies in DLBCL.
More Related Videos
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Inheritance of Chromatin Structures
Non-LTR Retrotransposons